Type 1 Diabetes News and Research RSS Feed - Type 1 Diabetes News and Research

Type 1 diabetes, formerly called juvenile diabetes or insulin-dependent diabetes, is usually first diagnosed in children, teenagers, or young adults. In this form of diabetes, the beta cells of the pancreas no longer make insulin because the body’s immune system has attacked and destroyed them. Treatment for type 1 diabetes includes taking insulin shots or using an insulin pump, making wise food choices, exercising regularly, controlling blood pressure and cholesterol, and taking aspirin daily—for some.
Researchers reveal molecular interplay between Roquin and RNA

Researchers reveal molecular interplay between Roquin and RNA

The Roquin protein, discovered in 2005, controls T-cell activation and differentiation by regulating the expression of certain mRNAs. In doing so, it helps to guarantee immunological tolerance and prevents immune responses against the body's own structures that can lead to autoimmune disease. [More]
Study to understand molecular interplay between Roquin and RNA to treat autoimmune diseases

Study to understand molecular interplay between Roquin and RNA to treat autoimmune diseases

Scientists at the Helmholtz Zentrum München, the Ludwig-Maximilians University of Munich (LMU) and the Technische Universität München (TUM) have moved an important step closer to understanding molecular mechanisms of autoimmune diseases. [More]
Researchers examine lives of diabetic pupils who receive inadequate support from schools

Researchers examine lives of diabetic pupils who receive inadequate support from schools

The project entitled 'Young people with diabetes and their peers' led by Dr Brooks - who is a psychologist with the University of Huddersfield's Centre for Applied Psychological and Health Research - set out to examine the lives of young diabetics from the age when they are starting to be more independent, they have now published their research. [More]
Researchers examine impact of birth on development of immune system in newborn mice

Researchers examine impact of birth on development of immune system in newborn mice

A number of studies suggest that children delivered by Caesarean section have a different intestinal flora than children delivered by natural birth. [More]
Acetone in breath is suitable marker of fat-burning during physical activity

Acetone in breath is suitable marker of fat-burning during physical activity

Physicists at Radboud University Nijmegen have shown for the first time that the concentration of acetone in breath is a suitable marker of fat-burning during physical activity. [More]
Screening genetically susceptible infants can help detect celiac disease at a very early age

Screening genetically susceptible infants can help detect celiac disease at a very early age

Physicians from the University of Colorado School of Medicine in collaboration with an international team of researchers have demonstrated that screening of genetically susceptible infants can lead to the diagnosis of celiac disease at a very early age. [More]
Switching off a single gene converts human gastrointestinal cells into insulin-producing cells

Switching off a single gene converts human gastrointestinal cells into insulin-producing cells

By switching off a single gene, scientists at Columbia University's Naomi Berrie Diabetes Center have converted human gastrointestinal cells into insulin-producing cells, demonstrating in principle that a drug could retrain cells inside a person's GI tract to produce insulin. [More]
Afrezza gets FDA approval to improve glycemic control in adults with diabetes mellitus

Afrezza gets FDA approval to improve glycemic control in adults with diabetes mellitus

The U.S. Food and Drug Administration today approved Afrezza (insulin human) Inhalation Powder, a rapid-acting inhaled insulin to improve glycemic control in adults with diabetes mellitus. Afrezza is a rapid-acting inhaled insulin that is administered at the beginning of each meal, or within 20 minutes after starting a meal. [More]
New study shows that bariatric patients face lower cancer risks

New study shows that bariatric patients face lower cancer risks

A new study published in the journal Obesity Surgery indicates that bariatric patients benefit from a significantly decreased risk of cancer compared to other obese patients. [More]
Pilot study to evaluate advanced artificial pancreas technology under real-world situations

Pilot study to evaluate advanced artificial pancreas technology under real-world situations

For several years, JDRF-funded researchers at the University of Virginia Center for Diabetes Technology have been hard at work designing an artificial pancreas system that would allow individuals with type 1 diabetes (T1D) to go about their daily lives and sleep through the night with less worry about life-threatening blood-sugar highs and lows. [More]
70% of adults with Type 1 diabetes never use blood glucose self-monitoring devices to download historical data

70% of adults with Type 1 diabetes never use blood glucose self-monitoring devices to download historical data

Almost 70 percent of adults with Type 1 diabetes never use their blood glucose self-monitoring devices or insulin pumps to download historical data about their blood sugar levels and insulin doses-information that likely would help them manage their disease better. [More]
Researchers find possible biological reason why people with diabetes are prone to depression

Researchers find possible biological reason why people with diabetes are prone to depression

Researchers have found a possible biological reason why people with diabetes are prone to depression. [More]
New research reveals gene's role in type 1 diabetes

New research reveals gene's role in type 1 diabetes

New research describes details of how a diabetes-related gene functions on a biological pathway that affects the release of insulin. The study authors say that finding drugs that act on that pathway may eventually lead to a new treatment for type 1 diabetes. [More]
Susceptibility gene for type 1 diabetes regulates self-destruction of cell's energy factory

Susceptibility gene for type 1 diabetes regulates self-destruction of cell's energy factory

A team led by researchers from the Perelman School of Medicine at the University of Pennsylvania found that a susceptibility gene for type 1 diabetes regulates self-destruction of the cell's energy factory. They report their findings this week in Cell. [More]
U of MD researchers to use $3.7 million NIH grant to develop novel method to treat monogenic diabetes

U of MD researchers to use $3.7 million NIH grant to develop novel method to treat monogenic diabetes

The National Institutes of Health has awarded a four-year, $3.7 million grant to researchers at the University of Maryland School of Medicine to develop a personalized medicine program to help doctors diagnose and treat monogenic diabetes - a form of diabetes caused by a mutation in a single gene. [More]
Animas' predictive algorithm technology maintains glucose above hypoglycemic levels

Animas' predictive algorithm technology maintains glucose above hypoglycemic levels

Animas Corporation today shared encouraging results from its predictive hypoglycemia-minimizing algorithm in development. [More]
No link between consumption of cow's milk-based formula and development of autoantibodies in kids

No link between consumption of cow's milk-based formula and development of autoantibodies in kids

There is no correlation between the consumption of a cow's milk-based formula or hydrolyzed protein formula and the development of diabetes-associated autoantibodies in children younger than seven, according to a worldwide research study published in the Journal of the American Medical Association (JAMA). [More]
Affordable Care Act to have significant impact on patients with diabetes

Affordable Care Act to have significant impact on patients with diabetes

The Affordable Care Act (ACA, also known as Obamacare) is dramatically changing health care delivery in the U.S. Specific parts of the new law, which will be phased in through 2020, will have a significant impact on patients with diabetes and prediabetes, as explored in a comprehensive Review article published in Diabetes Technology & Therapeutics, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. [More]
Scientists identify novel approach to treating multiple sclerosis

Scientists identify novel approach to treating multiple sclerosis

Scientists in the University of Connecticut's Technology Incubation Program have identified a novel approach to treating multiple sclerosis (MS) using human embryonic stem cells, offering a promising new therapy for more than 2.3 million people suffering from the debilitating disease. [More]
Bionic pancreas device controls blood sugar in patients with type 1 diabetes

Bionic pancreas device controls blood sugar in patients with type 1 diabetes

The latest version of a bionic pancreas device has been successfully tested in two five-day clinical trials - one in adults, the other in adolescents - that imposed minimal restrictions on patient activities. [More]